No special treatment given to hospitalized former Malaysian PM Najib: Khairy

0

PUTRAJAYA: There was no interference in the medical treatment of Najib Razak and the former Malaysian Prime Minister did not receive any special treatment while in hospital, Malaysian Health Minister Khairy Jamaluddin said on Wednesday September 21 .

Khairy said the Ministry of Health (MOH) conducts itself professionally in accordance with existing procedures and guidelines at all times.

The postponement of proceedings in Najib’s ongoing corruption trial was requested by a prosecutor so that Najib could seek treatment at the hospital, Khairy added.

Najib, who began serving a prison sentence for his corruption conviction last month, is currently being treated at Cheras Rehabilitation Hospital (HRC) in Kuala Lumpur, the prisons department said on Wednesday.

He was admitted to Kuala Lumpur Hospital (HKL) and underwent a series of treatments and tests. The hospital then referred him to HRC for further treatment and monitoring, the department added.

“We did this so that there would be no challenge from any party, from his family or from Najib himself, that any treatment was given to him,” Khairy told reporters on Wednesday.

“We have prepared all the necessary treatments and all the tests requested and carried out.”

He added that after Najib was referred to HKL, the former prime minister received training to perform self-rehabilitation treatment.

Khairy also said that medical specialists will hold a family conference with Najib and his family members to brief them on his latest health situation and treatment plan.

“I understand that after the family conference, Najib will be sent to Kajang prison immediately after medical specialists grant him medical release,” he said.

Specialists are preparing medical records to share with Najib’s family at the conference, said Khairy, who added that “it won’t be long” before Najib is sent back to prison.

Once the medical records are prepared, it means the specialists are satisfied, he said.

Share.

Comments are closed.